URL copied
Canada s largest province halts AstraZeneca doses over blood clot concerns
Canada s largest province said Tuesday it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots. Ontario s chief medical officer for health, Dr. David Williams, said the decision was made out of an abundance of caution because of increased instances of the rare blood clotting disorder linked to the shot. AstraZeneca is restricted in some European countries because of a potential link to extremely rare blood clots.
âOver the last few days there have been increased reports,â Williams said.
Canada s largest province said Tuesday it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots. Ontario s chief medical officer for health, Dr. David Williams, said the decision was made out of an abundance of caution because of increased instances of the rare blood clotting disorder linked to the shot.
AstraZeneca is restricted in some European countries because of a potential link to extremely rare blood clots. Over the last few days there have been increased reports, Williams said. We are reviewing the data to consider options for the use of the AstraZeneca vaccine for second doses and more broadly.
By ROB GILLIESMay 11, 2021 GMT
Prime Minister Justin Trudeau receives his first COVID-19 AstraZeneca vaccination in Ottawa on Friday April 23, 2021. (Adrian Wyld/The Canadian Press via AP)
Prime Minister Justin Trudeau receives his first COVID-19 AstraZeneca vaccination in Ottawa on Friday April 23, 2021. (Adrian Wyld/The Canadian Press via AP)
TORONTO (AP) Canada’s largest province said Tuesday it will stop giving out first doses of the Oxford-AstraZeneca coronavirus vaccine due to concerns over its link to rare blood clots.
Ontario’s chief medical officer for health, Dr. David Williams, said the decision was made out of an abundance of caution because of increased instances of the rare blood clotting disorder linked to the shot.
increase font size
Canada OKs Pfizer vaccine for ages 12 and older, U.S. expected to follow
The U.S. FDA is also expected to authorize Pfizer’s vaccine for young people by next week, setting up shots for many before the beginning of the next school year.
By ROB GILLIESAssociated Press
Share
Canada s Prime Minister Justin Trudeau speaks during a news conference in Ottawa April 23. Sean Kilpatrick/The Canadian Press via AP, File
TORONTO Canada’s health regulator has authorized Pfizer’s COVID-19 vaccine for ages 12 and older.
Dr. Supriya Sharma, chief medical adviser at Health Canada, on Wednesday confirmed the decision for the ages to 12 to 15 and said it will help children return to a normal life.
In late March, Pfizer released preliminary results from a vaccine study of 2,260 U.S. volunteers age 12 to 15 showing there were no cases of COVID-19 among fully vaccinated adolescents compares with